Skip to main content
OpenTrials

Clinical trial condition

Adenocarcinoma

Explore clinical trials studying Adenocarcinoma. Study availability and eligibility vary by location and protocol.

5,026 public trials 1,169 recruiting studies
Refine in advanced search Browse all conditions

Adenocarcinoma trial results

Recruiting

Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer

NCT06282575

Conditions
Adenocarcinoma, Biliary Tract Cancer, Biliary Tract Diseases, +11 more
Locations
  • City of Hope(City of Hope National Medical Center, City of Hope Medical Center) Duarte, California, United States
  • Rocky Mountain Cancer Centers, LLP Lone Tree, Colorado, United States
  • AdventHealth Hematology and Oncology Orlando, Florida, United States
  • Winship Cancer Institute Atlanta, Georgia, United States
View all 185 locations
View Trial Details
Recruiting

Digital Monitoring of Self-reported Symptoms by Patients Treated With Cabozantinib Plus Nivolumab for Advanced Clear-cell Renal Carcinoma

NCT07028125

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +20 more
Locations
  • Centre Hospitalier d'Annecy Annecy, France
  • Institut Sainte Catherine Avignon, France
  • Centre Hospitalier de Bayeux Bayeux, France
  • CH Boulogne sur Mer Boulogne-sur-Mer, France
View all 19 locations
View Trial Details
Recruiting

A Study of Pembrolizumab in Japanese Pediatric Participants With Solid Tumors or Lymphomas and Japanese Adult Participants With Merkel Cell Carcinoma (MK-3475-G21/KEYNOTE-G21)

NCT07302347

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +20 more
Locations
  • Nagoya City University Hospital ( Site 0003) Nagoya, Aichi-ken, Japan
  • Nagoya City University Hospital ( Site 0007) Nagoya, Aichi-ken, Japan
  • Sapporo Hokuyu Hospital ( Site 0005) Sapporo, Hokkaido, Japan
  • Hyogo Prefectural Kobe Children's Hospital ( Site 0006) Kobe, Hyōgo, Japan
View Trial Details
Recruiting

Combination of GNS561 and Trametinib in Patients With Advanced KRAS Mutated Cholangiocarcinoma

NCT05874414

Conditions
Adenocarcinoma, Bile Duct Diseases, Bile Duct Neoplasms, +10 more
Locations
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • LACN Aneheim Flagship Office Los Angeles, California, United States
  • Orlando Health Orlando, Florida, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View Trial Details

Related conditions